239 related articles for article (PubMed ID: 1899899)
1. Pravastatin and simvastatin for hypercholesterolemia.
Med Lett Drugs Ther; 1991 Mar; 33(839):18-20. PubMed ID: 1899899
[No Abstract] [Full Text] [Related]
2. Clinical implications of new drugs for lowering plasma cholesterol concentrations.
Illingworth DR
Drugs; 1991 Feb; 41(2):151-60. PubMed ID: 1709846
[No Abstract] [Full Text] [Related]
3. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
Aronson JK; Ng LL
Q J Med; 1990 Feb; 74(274):111-5. PubMed ID: 2111916
[No Abstract] [Full Text] [Related]
4. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
Maher VM; Thompson GR
Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different HMG-CoA reductase inhibitors.
Ditschuneit HH; Kuhn K; Ditschuneit H
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S27-32. PubMed ID: 1904357
[TBL] [Abstract][Full Text] [Related]
6. Lipid lowering drugs.
Bocanegra TS; Tobert JA
BMJ; 1990 May; 300(6733):1195. PubMed ID: 2112035
[No Abstract] [Full Text] [Related]
7. [Simvastatin-induced hepatitis].
Roblin X; Becot F; Piquemal A; Baziz A
Gastroenterol Clin Biol; 1992; 16(1):101. PubMed ID: 1537472
[No Abstract] [Full Text] [Related]
8. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Pincus J
Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683
[No Abstract] [Full Text] [Related]
9. [Hypercholesterolemia: therapeutic approach].
Alessandri C; Peverini F
Clin Ter; 1991 Jun; 137(6):373-97. PubMed ID: 1832610
[TBL] [Abstract][Full Text] [Related]
10. Worldwide experience with simvastatin/lovastatin.
Walker JF
Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
[No Abstract] [Full Text] [Related]
11. Pravastatin--ocular side effects after a two year follow-up?
Behrens-Baumann W; Thiery J; Fieseler HG; Seidel D
Lens Eye Toxic Res; 1990; 7(3-4):311-8. PubMed ID: 2129219
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy and safety of pravastatin in primary hypercholesterolemia].
Craveri A; Citella C; Lanfredini M; Colombo L; Bruschi R
Boll Chim Farm; 1990 Jun; 129(6):10S-15S. PubMed ID: 2127364
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
Golay A; Lehmann T; James R; Pometta D
Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
[TBL] [Abstract][Full Text] [Related]
14. Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms.
Owens D; Collins P; Johnson A; Tighe O; Robinson K; Tomkin GH
Biochim Biophys Acta; 1991 Apr; 1082(3):303-9. PubMed ID: 1903069
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin, pravastatin and lovastatin: three options for lowering cholesterol.
Holdcroft C
Nurse Pract; 1993 May; 18(5):56-7. PubMed ID: 8355901
[No Abstract] [Full Text] [Related]
16. Pravastatin versus simvastatin--what happens in the real world?
Levenstein S
S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696
[No Abstract] [Full Text] [Related]
17. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia.
Cutler N; Sramek J; Veroff A; Block G; Stauffer L; Lines C
Br J Clin Pharmacol; 1995 Mar; 39(3):333-6. PubMed ID: 7619678
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
[TBL] [Abstract][Full Text] [Related]
19. Clinical investigation on the hypolipidemic effect of simvastatin in primary hypercholesterolemia.
Saba P; Galeone F; Giuntoli F; Spagnolo G; Brunelleschi G; Lamanna F; Angelé B
Clin Ter; 1992 Jan; 140(1 Pt 2):3-9. PubMed ID: 1559319
[TBL] [Abstract][Full Text] [Related]
20. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
Phillips PS
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
